Source comparison
BPC-157 Research Failure Modes: Protocol Comparison
Storage Degradation Peptide denaturation above 8°C breaks disulfide bonds 15–30% potency loss within 8 weeks at 4°C; study shows reduced or null effect Store lyophilised peptide at −20°C; refrigerate reconstituted peptide at 2–8°C; never refreeze thawed vials
This comparison does not assign a generated winner or score.
- Storage Degradation
- Peptide denaturation above 8°C breaks disulfide bonds
- 15–30% potency loss within 8 weeks at 4°C; study shows reduced or null effect
- Store lyophilised peptide at −20°C; refrigerate reconstituted peptide at 2–8°C; never refreeze thawed vials
- Mass spectrometry or HPLC purity testing at study start and midpoint
- Reconstitution Contamination
- Bacterial endotoxins introduce inflammatory confounders
- Wide variance in inflammatory markers; unpredictable dose response
- Use bacteriostatic water for multi-dose vials; aseptic technique throughout; discard vials >28 days post-reconstitution
- Visual inspection for cloudiness; LAL endotoxin assay if variance detected
- Dosing Inconsistency
- Volume variance compounds across repeated injections
- High standard deviation; low statistical power; irreproducible results
- Calibrate micropipettes gravimetrically; use syringes with ≤0.01 mL graduations; draw from vial centre
- Document delivered volume per dose; weigh pre/post-injection if syringe-based